I’m excited about it because it’s supposed to be effective, yet safer than risperidone or aripiprazole.
At least in phase 2 it did not have metabolic or prolactin effects. I’m sure it will have side effects. But hopefully better than existing.
Also it may have some cognitive benefits, although the trial endpoints are based on its antipsychotic properties.